Hong Kong · Delayed Price · Currency is HKD Giant Biogene Holding Statistics
Total Valuation
HKG:2367 has a market cap or net worth of HKD 24.89 billion. The enterprise value is 16.38 billion.
| Market Cap | 24.89B |
| Enterprise Value | 16.38B |
Important Dates
The next estimated earnings date is Wednesday, November 18, 2026.
| Earnings Date | Nov 18, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
HKG:2367 has 1.06 billion shares outstanding. The number of shares has increased by 4.19% in one year.
| Current Share Class | 1.06B |
| Shares Outstanding | 1.06B |
| Shares Change (YoY) | +4.19% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 55.28% |
| Owned by Institutions (%) | 14.47% |
| Float | 474.77M |
Valuation Ratios
The trailing PE ratio is 12.91 and the forward PE ratio is 10.43. HKG:2367's PEG ratio is 1.08.
| PE Ratio | 12.91 |
| Forward PE | 10.43 |
| PS Ratio | 4.05 |
| PB Ratio | 2.30 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | 13.16 |
| P/OCF Ratio | 11.62 |
| PEG Ratio | 1.08 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.89, with an EV/FCF ratio of 8.66.
| EV / Earnings | 8.48 |
| EV / Sales | 2.66 |
| EV / EBITDA | 7.89 |
| EV / EBIT | 8.31 |
| EV / FCF | 8.66 |
Financial Position
The company has a current ratio of 10.63, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.63 |
| Quick Ratio | 9.96 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 4,780.68 |
Financial Efficiency
Return on equity (ROE) is 18.01% and return on invested capital (ROIC) is 70.93%.
| Return on Equity (ROE) | 18.01% |
| Return on Assets (ROA) | 9.80% |
| Return on Invested Capital (ROIC) | 70.93% |
| Return on Capital Employed (ROCE) | 17.84% |
| Weighted Average Cost of Capital (WACC) | 8.29% |
| Revenue Per Employee | 2.65M |
| Profits Per Employee | 832,608 |
| Employee Count | 2,319 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.80 |
Taxes
In the past 12 months, HKG:2367 has paid 380.24 million in taxes.
| Income Tax | 380.24M |
| Effective Tax Rate | 16.46% |
Stock Price Statistics
The stock price has decreased by -58.51% in the last 52 weeks. The beta is 0.73, so HKG:2367's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -58.51% |
| 50-Day Moving Average | 27.07 |
| 200-Day Moving Average | 29.77 |
| Relative Strength Index (RSI) | 35.67 |
| Average Volume (20 Days) | 2,476,582 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2367 had revenue of HKD 6.15 billion and earned 1.93 billion in profits. Earnings per share was 1.82.
| Revenue | 6.15B |
| Gross Profit | 4.86B |
| Operating Income | 1.95B |
| Pretax Income | 2.31B |
| Net Income | 1.93B |
| EBITDA | 2.04B |
| EBIT | 1.95B |
| Earnings Per Share (EPS) | 1.82 |
Balance Sheet
The company has 8.54 billion in cash and 14.15 million in debt, with a net cash position of 8.52 billion or 8.03 per share.
| Cash & Cash Equivalents | 8.54B |
| Total Debt | 14.15M |
| Net Cash | 8.52B |
| Net Cash Per Share | 8.03 |
| Equity (Book Value) | 10.82B |
| Book Value Per Share | 10.18 |
| Working Capital | 8.69B |
Cash Flow
In the last 12 months, operating cash flow was 2.14 billion and capital expenditures -249.42 million, giving a free cash flow of 1.89 billion.
| Operating Cash Flow | 2.14B |
| Capital Expenditures | -249.42M |
| Depreciation & Amortization | 94.08M |
| Net Borrowing | -10.89M |
| Free Cash Flow | 1.89B |
| FCF Per Share | 1.78 |
Margins
Gross margin is 79.07%, with operating and profit margins of 31.70% and 31.42%.
| Gross Margin | 79.07% |
| Operating Margin | 31.70% |
| Pretax Margin | 37.59% |
| Profit Margin | 31.42% |
| EBITDA Margin | 33.21% |
| EBIT Margin | 31.70% |
| FCF Margin | 30.36% |
Dividends & Yields
This stock pays an annual dividend of 1.41, which amounts to a dividend yield of 6.02%.
| Dividend Per Share | 1.41 |
| Dividend Yield | 6.02% |
| Dividend Growth (YoY) | 6.39% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 115.39% |
| FCF Payout Ratio | 77.98% |
| Buyback Yield | -4.19% |
| Shareholder Yield | 1.84% |
| Earnings Yield | 7.76% |
| FCF Yield | 7.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:2367 is 37.40, which is 59.56% higher than the current price. The consensus rating is "Buy".
| Price Target | 37.40 |
| Price Target Difference | 59.56% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 12.65% |
| EPS Growth Forecast (3Y) | 5.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2367 has an Altman Z-Score of 28.96 and a Piotroski F-Score of 5.
| Altman Z-Score | 28.96 |
| Piotroski F-Score | 5 |